Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 35 pseudogene (RNU7-35P) is a pseudogene, meaning it is a non-functional segment of DNA similar to the gene encoding U7 small nuclear RNA (U7 snRNA)[4][7][8]. U7 snRNA is an essential component of the U7 small nuclear ribonucleoprotein complex involved in the 3'-end processing of replication-dependent histone pre-mRNAs[2][3]. However, as a pseudogene, RNU7-35P does not encode a functional RNA and does not contribute to biological functions or disease mechanisms[4][7]. Pseudogenes like RNU7-35P are not known to be therapeutic targets or have roles in drug interactions, biomarkers, or clinical safety concerns. Key notes: RNU7-35P is not a functional gene or active target; it is one of several reverse-transcribed pseudogenes for human U7 snRNA[4][7][8]. Pseudogenes are generally not considered in therapeutic targeting, disease associations, or mechanistic drug action contexts[4]. The canonical gene for functional U7 snRNA is RNU7-1[1][2]; confusion may arise when pseudogene names are mistaken for active targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 35 pseudogene (RNU7-35P).